Clinical Trials: Study of Pegfilgrastim Administered to Subjects With Newly Diagnosed, Locally-advanced or Metastatic Colorectal Cancer Treated With Bevacizumab and Either FOLFOX or FOLFIRI
Sponsor and CollaboratorsAmgen
Contact
Amgen Call Center
866-572-6436
Principal Investigator
MD Amgen
ClinicalTrials.gov Identifier
NCT00911170
